Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 600x60px
Document › Details

Protea Biosciences Group, Inc.. (2/2/16). "Press Release: Protea to Present at the BIO CEO & Investor Conference in New York City February 8 at 8:30 AM ET". Morgantown, WV.

Region Region New York, NY
  Country United States (USA)
Organisations Organisation Protea Biosciences Group Inc.
  Group Protea Biosciences (Group)
  Organisation 2 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization)
Products Product BIO CEO & Investor Conference 2016 New York
  Product 2 LAESI technology (Laser Ablation Electrospray Ionization technology)
Index term Index term Protea Biosciences–BIO (US): investor conference, 201602 supply service Protea presents at BIO CEO & Investor Conference NY
Person Person Turner, Stephen (Steve) (Protea Biosciences 201002 CEO)
     


Presentation to be Webcast


Protea Biosciences Group, Inc., (OTCQB:PRGB) announced that the Company will be presenting at the BIO CEO & Investor Conference taking place on February 8-9, 2016 at the Waldorf Astoria Hotel in New York City. Stephen Turner, Chairman and CEO, will present at 8:30 am ET on Monday, February 8, 2016.

To listen to the live audio webcast of the presentation during the event, please visit:

http://www.veracast.com/webcasts/bio/ceoinvestor2016/34103292263.cfm

A replay of the webcast will be available for 90 days after the initial presentation.

Management will be available for one-on-one meetings with conference attendees. Meetings can be arranged through the conference's partnering system at http://www.bio.org/events/conferences/bio-ceo-investor-conference or by contacting the Company at jesse.ayers@proteabio.com.


About Protea Biosciences

Protea Biosciences Group, Inc. (OTCQB:PRGB) is a molecular information company providing innovative bio-analytical technology to the pharmaceutical and life science industries. "Molecular information" refers to the generation and bioinformatic processing of very large data sets, obtained by applying the Company's proprietary technology to identify and characterize the proteins, metabolites, lipids and other biomolecules which are the byproducts of all living cells and life forms.

For more Information:
Protea Biosciences Group, Inc., 1311 Pineview Dr., Morgantown, WV 26505 USA
Phone: 304.292.2226 Fax: 304.606.3049

https://proteabio.com/investors
stephen.turner@proteabio.com

Protea is a registered trademark of Protea Biosciences Group, Inc.

   
Record changed: 2017-07-02

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Protea Biosciences (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px